athira pharma stock forecast cnn
Athira Pharma Inc NASDAQ. Athira is currently advancing its lead therapeutic candidate fosgonimeton ATH-1017 a novel small molecule for Alzheimers Parkinsons disease dementia and dementia with Lewy bodies.
Sec Filing Athira Pharma
Stock falls 68 Shares of Athira Pharma Inc.
. ATHA -174 tumbled 680 in premarket. Stock Price Forecast The 6 analysts offering 12-month price forecasts for aTyr Pharma Inc have a median target of 2000 with a high estimate of 3500 and a low estimate of 1400. Please note that any opinions estimates or forecasts regarding Athira Pharmas performance made by these analysts are theirs alone and do not represent opinions forecasts or.
What is ATHAs Earnings Per Share EPS. Athira Pharma StockDown 23. Athira says its Alzheimers treatment did not meet endpoint in mid-stage trial.
Athira Pharma Presents Study Overview and Baseline Data from ACT-AD Phase 2 Trial of Fosgonimeton in Mild-to-Moderate Alzheimers Disease at the 2022 ADPD. Nasdaqatha azienda biofarmaceutica in fase avanzata di sviluppo clinico e focalizzata sullo. The median estimate represents a 1285.
However When quite a few insiders buy shares as it happened in Athira Pharma Incs NASDAQATHA case its. Athira Pharma Provides Update on Plans for Ongoing LIFT-AD Clinical Study of Fosgonimeton in Mild-to-Moderate Alzheimers Patients. The 9 analysts offering price forecasts for Athira Pharma have a median target of 2389 with a high estimate of 5300 and a low estimate of 300.
ATHA stock price news historical charts analyst ratings and financial information from WSJ. ATHA stockopened at 387 on Thursday. Find the latest Financials data for Athira Pharma Inc.
View the latest Athira Pharma Inc. Real-time trade and investing ideas on Athira Pharma Inc ATHA from the largest community of traders and investors. ATHA announced an update to its plans for the ongoing LIFT-AD trial of fosgonimeton ATH-1017 for mild-to-moderate Alzheimers disease AD.
The average Athira Pharma stock price prediction forecasts a potential upside of 31026 from the current ATHA share price of 390. It is usually uneventful when a single insider buys stock. Rooms Rankings Earnings Newsletters Shop.
Bothell wash 15 agosto 2022 globe newswire -- athira pharma inc. Athira Pharma Inc. ATHA 10-Q Quarterly Report Mon Aug 15 2022.
Athira Drama Not Over Yet As Investor And Ally Of Former Ceo Calls For Another C Suite Change Fierce Biotech
Bothell Biotech Firm And Activist Investor Feud Over Control Of Alzheimer S Research The Seattle Times
Athira Alzheimer S Drug Fails Mid Stage But The Biotech Still Eyes A Phase 3 Path Medcity News
Insiders Turn Bullish On Athira Pharma Shares Rise
Latest Drama At Athira Investor Calls For Ceo Replacement And Wants Two Board Seats Geekwire
Athira Pharma Shares Drop Nearly 70 On Release Of Clinical Trial Data For Alzheimer S Disease Geekwire
Bothell Biotech Firm And Activist Investor Feud Over Control Of Alzheimer S Research The Seattle Times
C469b519 0d38 400b 957e E55ae48b2509 Jpg
Lateral Sclerosis Disease Malacards Research Articles Drugs Genes Clinical Trials
Athira Pharma Inc Atha Stock Price Quote News Stock Analysis
Athira Pharma Stock Tanks After Announcing Results From Alzheimer S Study
Atha Institutional Ownership And Shareholders Athira Pharma Inc Nasdaq Stock
Episode 19 31 Predicting Weather Data Computers And Your Smartphone By Technation Radio Podcast
Atha Stock Price And Chart Nasdaq Atha Tradingview
Saupload My Stuff Device Stack Networks Thumb1 Png
Athira Pharma Ceo Placed On Leave Amid Claims Of Altered Images Stat
Peloton Stock Jpg
Insiders Turn Bullish On Athira Pharma Shares Rise
70d9a30d 2a7d 4fd4 A93e 176e1621c9a3 Jpg